SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CAMARDA, Valeria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.893
AS - Asia 1.862
EU - Europa 1.030
SA - Sud America 218
AF - Africa 37
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.045
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.823
SG - Singapore 669
CN - Cina 516
VN - Vietnam 219
DE - Germania 212
UA - Ucraina 170
BR - Brasile 168
GB - Regno Unito 163
IT - Italia 133
TR - Turchia 130
HK - Hong Kong 118
FI - Finlandia 97
FR - Francia 62
SE - Svezia 55
IN - India 44
JP - Giappone 42
CA - Canada 40
RU - Federazione Russa 39
MX - Messico 25
PK - Pakistan 22
NL - Olanda 20
BD - Bangladesh 19
PL - Polonia 19
AR - Argentina 18
IQ - Iraq 16
ZA - Sudafrica 15
BE - Belgio 12
ID - Indonesia 12
CO - Colombia 10
ES - Italia 10
LT - Lituania 9
UZ - Uzbekistan 9
TN - Tunisia 7
AE - Emirati Arabi Uniti 6
AT - Austria 6
EC - Ecuador 6
MA - Marocco 6
SA - Arabia Saudita 6
CL - Cile 5
MY - Malesia 5
PH - Filippine 5
IE - Irlanda 4
AU - Australia 3
BG - Bulgaria 3
CH - Svizzera 3
EG - Egitto 3
IL - Israele 3
PY - Paraguay 3
TH - Thailandia 3
UY - Uruguay 3
VE - Venezuela 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
BH - Bahrain 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
ET - Etiopia 2
IR - Iran 2
JM - Giamaica 2
KR - Corea 2
KZ - Kazakistan 2
RO - Romania 2
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GE - Georgia 1
HU - Ungheria 1
JO - Giordania 1
KE - Kenya 1
KW - Kuwait 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MT - Malta 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
SV - El Salvador 1
Totale 8.045
Salva come PNG Salva come JPEG
Città #
Dallas 800
Fairfield 475
Singapore 460
Ashburn 449
Woodbridge 431
Houston 252
Jacksonville 188
Seattle 178
Chandler 173
Beijing 171
San Jose 164
Cambridge 161
Santa Clara 148
Ann Arbor 139
Wilmington 136
Hong Kong 117
New York 78
Munich 70
Los Angeles 68
Nanjing 64
Ho Chi Minh City 63
Izmir 62
San Diego 47
Milan 43
Tokyo 41
Princeton 40
Helsinki 34
Boardman 33
Hanoi 33
Shanghai 33
Lauterbourg 32
London 27
Dong Ket 26
Turku 26
Ferrara 24
Dearborn 22
Bremen 20
São Paulo 20
Orem 19
Addison 16
Hebei 16
Mcallen 16
Mexico City 16
Shenyang 16
Brooklyn 14
Nanchang 14
Warsaw 14
Hefei 13
Auburn Hills 12
Buffalo 12
Lahore 12
Montréal 12
Brussels 11
Denver 11
Frankfurt am Main 11
Tianjin 11
Amsterdam 10
Atlanta 10
Changsha 10
San Francisco 10
Falkenstein 9
Haiphong 9
Manchester 9
Norwalk 9
Philadelphia 9
Stockholm 9
Baghdad 8
Chennai 8
Da Nang 8
Johannesburg 8
Montreal 8
Toronto 8
Boston 7
Chicago 7
Council Bluffs 7
Jiaxing 7
Jinan 7
Moscow 7
New Delhi 7
Ningbo 7
Padova 7
Phoenix 7
Rio de Janeiro 7
Tashkent 7
Bexley 6
Biên Hòa 6
Charlotte 6
Guangzhou 6
Mountain View 6
Dhaka 5
Falls Church 5
Indiana 5
Poplar 5
Tappahannock 5
Ankara 4
Bologna 4
Can Tho 4
Dublin 4
Elk Grove Village 4
Hải Dương 4
Totale 5.899
Salva come PNG Salva come JPEG
Nome #
1,4-Dioxolane-triazaspirodecanone derivatives as nociceptin/orphanin FQ receptor ligands 991
Chimeric G proteins in fluorimetric calcium assays: Experience with opioid receptors 331
[Dmt(1) ]N/OFQ(1-13)-NH(2) , a potent nociceptin/orphanin FQ and opioid receptor universal agonist. 253
A new ligand for the urotensin II receptor 252
[(t)Bu-d-Gly(5)]NPS, a pure and potent antagonist of the neuropeptide S receptor: In vitro and in vivo studies 236
Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4′-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide 234
Cell and tissue responses of a range of Urotensin II analogs at cloned and native urotensin II receptors. Evidence for coupling promiscuity 219
Conformation-activity relationship of neuropeptide S and some structural mutants: Helicity affects their interaction with the receptor 219
Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24 209
In vitro and in vivo pharmacological characterization of the novel NK(1) receptor selective antagonist Netupitant. 207
Pharmacological characterisation of novel kinin B2 receptor ligands 206
null 205
Further studies at neuropeptide S position 5: Discovery of novel neuropeptide S receptor antagonists 205
Synthesis and biological activity of human neuropeptide S analogues modified in position 2 204
Effects of human urotensin II in isolated vessels of various species; comparison with other vasoactive agents 204
[Arg(14), Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies 200
Urotensin II stimulates plasma extravasation in mice via UT receptor activation 196
Synthesis and Biological Activity of Human Neuropeptide S Analogues Modified in Position 5: Identification of Potent and Pure Neuropeptide S Receptor Antagonists 193
Inhibitory effects of putative peptidic urotensin-II receptor antagonists on urotensin-II-induced contraction of cat isolated respiratory smooth muscle 192
Structure-activity study at positions 3 and 4 of human neuropeptide S. 192
Synthesis and separation of the enantiomers of the neuropeptide S receptor antagonist (9R/S)-3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide (SHA 68). 188
Differential agonistic and antagonistic effects of the urotensin-II ligand SB-710411 at rodent and primate UT receptors 187
In vitro and in vivo pharmacological characterization of the neuropeptide S receptor antagonist [D-Cys(tBu)5]neuropeptide S 184
Pharmacological profile of NOP receptors coupled with calcium signaling via the chimeric protein Gαqi5 179
Structure-activity relationship study of position 4 in the urotensin-II receptor ligand U-II(4-11) 178
In vitro and in vivo pharmacological characterization of the novel neuropeptide S receptor ligands QA1 and PI1 176
Comparative biochemical and pharmacological characterization of a novel, NOP receptor selective hexapeptide, Ac-RYYRIR-ol 176
Structure-activity relationship study on human urotensin II 172
In vitro and in vivo pharmacological characterization of the novel UT receptor ligand [Pen(5), DTrp(7), Dab(8)] urotensin II(4-11) (UFP-803) 169
Pharmacological profile of hemokinin 1: a novel member of the tachykinin family 168
Urantide mimics urotensin-II induced calcium release in cells expressing recombinant UT receptors 167
Structure-activity relationship study on Tyr9 of urotensin-II(4-11): Identification of a partial agonist of the UT receptor 165
The peptidic urotensin-II receptor ligand GSK248451 possesses less intrinsic activity than the low-efficacy partial agonists SB-710411 and urantide in native mammalian tissues and recombinant cell systems 152
Synthesis and Structure-Activity Relationships of (-)-cis-N-Normetazocine-Based LP1 Derivatives 137
Pharmacological profile and antiparkinsonian properties of the novel nociceptin/orphanin FQ receptor antagonist 1-[1-Cyclooctylmethyl-5-(1-hydroxy-1-methyl-ethyl)-1,2,3,6-tetrahydro-pyridin-4-yl]-3-ethyl-1,3-dihydro-benzoimidazol-2-one (GF-4). 106
Further studies on the pharmacological profile of the neuropeptide S receptor antagonist SHA 68. 105
null 94
null 87
null 78
Synthesis and Structure–Activity Relationships of Triazaspirodecanone Derivatives as Nociceptin/Orphanin FQ Receptor Ligands 64
Totale 8.080
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.952
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 910
Totale 31.862
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021174 0 0 0 0 0 0 0 0 0 59 61 54
2021/2022456 17 52 54 5 31 14 31 26 13 41 41 131
2022/2023439 43 26 15 51 79 59 34 35 56 1 21 19
2023/2024266 21 32 15 8 8 59 11 21 3 4 16 68
2024/2025922 35 27 105 23 108 92 23 36 123 74 137 139
2025/20263.087 292 274 782 322 397 190 289 116 199 226 0 0
Totale 8.080